You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 338.4% |
| Latest | Forecast | |
|---|---|---|
| P/E | -0.9 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | 7.3 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | n/a | -2.24 | -703.75p | -4.0 | 0.0 | n/a | n/a | 0.0% |
| 2016-12-31 | n/a | -5.75 | -1,067.50p | -0.6 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | n/a | -3.55 | -237.50p | -2.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -4.83 | -117.50p | -0.9 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -2.72 | -32.50p | -0.5 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 0.00 | 0.00 | 0.00p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-12-31 | 0.00 | 0.00 | 0.00p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| ValiRx looks to build on portfolio of drug candidates Sharecast News | 06 Jul |
|---|---|
| ValiRx enters collaboration agreement for Covid-19 treatment Sharecast News | 02 Jun |
| ValiRx offloads non-core IP to DDTech Sharecast News | 29 May |
| Exercise of Warrants and Warrant Update | 14-Sep-20 07:06 |
|---|---|
| Holding(s) in Company | 09-Sep-20 18:02 |
| Holding(s) in Company | 08-Sep-20 16:04 |
| Exercise of Warrant | 07-Sep-20 13:31 |
| Half-year Report | 07-Sep-20 07:03 |